-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
September 01, 2014 - chronic urinary retention (CUR) is a common problem
for which we have little understanding in terms of prevalence
-
digital.ahrq.gov/sites/default/files/docs/biblio/09-0054-EF-Updated_0.pdf
June 01, 2009 - randomized trial of the effectiveness of on- Violation Prevalence After Introduction of a Bar
demand
-
www.ahrq.gov/sites/default/files/wysiwyg/cpi/about/mission/budget/2021/FY_2021_CJ_NIRSQ.pdf
January 01, 2021 - Given the importance, prevalence, and negative health effects of HIV, the USPSTF sought to
review whether
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - clinical expert noted, “Diabetic macular edema is more common in racial/ethnic groups with a
higher prevalence
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_disposition-comments.pdf
November 01, 2010 - Executive
Summary
estimated average prevalence of one in 110 We have deleted the word "average."
-
cdsic.ahrq.gov/sites/default/files/2025-09/For%20508%20Approval_MO%20Level%203%20Respondent%20Burden%20Report%208.21.25.pdf
January 01, 2025 - Measurement and Outcomes Workgroup: Considerations for Minimizing Respondent Burden in Collecting Data for Patient-Centered Clinical Decision Support
Measurement and Outcomes
Workgroup:
Considerations for Minimizing
Respondent Burden in Collecting
Data for Patient-Centered Clinical
Decision Support
Agency for…
-
www.ahrq.gov/sites/default/files/2024-01/lambert-report.pdf
January 01, 2024 - Final Progress Report: TOP-MEDS CERT: Tools for Optimizing Medication Safety
Principal Investigator: Lambert, Bruce L. (Grant No. U19HS021093)
Northwestern University
TOP-MEDS CERT: Tools for Optimizing Medication Safety
Final Report, September 1, 2011, to August 30, 2017
Submitted November 20, 2017
This proje…
-
www.ahrq.gov/research/findings/nhqrdr/2014chartbooks/hispanichealth/hisph-slides-pt3.html
May 01, 2018 - Chartbook on Hispanic Health Care: Slide Presentation—Part 3
2014 National Healthcare Quality and Disparities Report
Trends in Access and Priorities of the National Quality Strategy
Slide 1
National Healthcare Quality and Disparities Report Chartbook on Health Care for Hispanics
Part 3: Trends in Acce…
-
digital.ahrq.gov/sites/default/files/For%20508%20Approval_MO%20Level%203%20Respondent%20Burden%20Report%208.21.25.pdf
September 01, 2025 - Measurement and Outcomes Workgroup: Considerations for Minimizing Respondent Burden in Collecting Data for Patient-Centered Clinical Decision Support
Measurement and Outcomes
Workgroup:
Considerations for Minimizing
Respondent Burden in Collecting
Data for Patient-Centered Clinical
Decision Support
Agency for…
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs023328-koopman-final-report-2021.pdf
January 01, 2021 - Optimizing Display of Blood Pressure Data to Support Clinical Decision Making - Final Report
FINAL PROGRESS REPORT
Optimizing Display…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction
September 03, 2019 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Recommendation Statement
Breast Cancer: Medication Use to Reduce Risk
September 03, 2019
Recommendations made by the USPSTF are independent of the U.S. government. Th…
-
effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
October 01, 2007 - ORIGINAL ARTICLE
Assessment of Adherence to and Persistence on
Disease-Modifying Antirheumatic Drugs (DMARDs) in
Patients With Rheumatoid Arthritis
Carlos G. Grijalva, MD, MPH,* Cecilia P. Chung, MD, MPH,† Patrick G. Arbogast, PhD,*‡
Charles M. Stein, MD,† Edward F. Mitchel, Jr, MS,* and Marie R. Griffin, MD, MPH*§¶…
-
digital.ahrq.gov/sites/default/files/docs/citation/u19hs021093-lambert-final-report-2017.pdf
January 01, 2017 - Tools for Optimizing Medication Safety (TOP-MEDS) - Final Report
…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023qdr-data-sources.pdf
December 01, 2023 - Therefore, estimates of
incidence and prevalence of disease cannot be computed. … It includes information
on the incidence, prevalence, morbidity, and mortality of this population, as
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/evidence-based-reports/nutrtp6.pdf
May 01, 2013 - Long-term vitamin C supplement use and prevalence
of early age-related lens opacities. … Magnesium intake, C-reactive protein, and the prevalence
of metabolic syndrome in middle-aged and older
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
October 25, 2010 - Prevalence of tamoxifen use for breast
cancer chemoprevention among U.S.
women. … The
prevalence of hereditary breast/ovarian
cancer risk in patients with a history of
breast or ovarian
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
September 01, 2010 - Prevalence of tamoxifen use for breast
cancer chemoprevention among U.S.
women. … The
prevalence of hereditary breast/ovarian
cancer risk in patients with a history of
breast or
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_executive.pdf
January 01, 2010 - Studies in the elderly are important, as diabetes
prevalence increases with age2 and older individuals … Diabetes Data &
Trends: Crude and Age-Adjusted Prevalence of Diagnosed Diabetes
per 100 Population,
-
digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-year3-final-report-2019.pdf
January 01, 2019 - consumers to help them
self-manage the entire healthcare process. b.well’s mission is “to reduce the prevalence … agreement by b.well that the CDS was valuable and contributed to their overall mission to reduce
the prevalence
-
effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_disposition-comments.pdf
February 29, 2016 - Rheumatol
24155165Hoy D Bain C Williams G
March L Brooks P et al 2012 A
systematic review of the global
prevalence … Reviewer
(North
American
Spine Society)
A body of evidence suggests that there
exists a high prevalence